1. Home
  2. OPFI vs SMTI Comparison

OPFI vs SMTI Comparison

Compare OPFI & SMTI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo OppFi Inc.

OPFI

OppFi Inc.

HOLD

Current Price

$9.96

Market Cap

254.2M

Sector

Finance

ML Signal

HOLD

Logo Sanara MedTech Inc.

SMTI

Sanara MedTech Inc.

HOLD

Current Price

$24.84

Market Cap

208.2M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
OPFI
SMTI
Founded
2009
1982
Country
United States
United States
Employees
445
N/A
Industry
Finance: Consumer Services
Medical/Dental Instruments
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
254.2M
208.2M
IPO Year
N/A
2008

Fundamental Metrics

Financial Performance
Metric
OPFI
SMTI
Price
$9.96
$24.84
Analyst Decision
Buy
Strong Buy
Analyst Count
2
2
Target Price
$14.25
$34.00
AVG Volume (30 Days)
817.4K
57.3K
Earning Date
05-07-2026
05-12-2026
Dividend Yield
2.72%
N/A
EPS Growth
N/A
N/A
EPS
N/A
0.05
Revenue
N/A
$15,586,976.00
Revenue This Year
$97.52
$17.31
Revenue Next Year
$10.95
$12.48
P/E Ratio
$67.57
$496.80
Revenue Growth
N/A
32.47
52 Week Low
$7.36
$16.05
52 Week High
$12.60
$35.70

Technical Indicators

Market Signals
Indicator
OPFI
SMTI
Relative Strength Index (RSI) 68.36 62.65
Support Level $9.72 $20.47
Resistance Level $10.26 $26.48
Average True Range (ATR) 0.40 1.38
MACD 0.18 0.21
Stochastic Oscillator 91.02 97.59

Price Performance

Historical Comparison
OPFI
SMTI

About OPFI OppFi Inc.

OppFi Inc is a tech-enabled, mission-driven specialty finance platform that broadens the reach of community banks to extend credit access to everyday Americans. It recognizes revenue through finance charges on installment and SalaryTap contracts based on the interest method.

About SMTI Sanara MedTech Inc.

Sanara MedTech Inc is a medical technology company focused on developing and commercializing technologies to improve clinical outcomes and reduce healthcare expenditures in the surgical market. It markets and sells soft tissue repair and bone fusion products for use in operating rooms and sterile environments. Its soft tissue repair products include CellerateRX Surgical Powder, a hydrolyzed collagen used in management of surgical wounds, and BIASURGE Surgical Solution, a sterile no-rinse solution for wound irrigation, while its bone fusion products include BiFORM Bioactive Moldable Matrix, an osteoconductive implant that supports bone growth, and ALLOCYTE Plus Viable Bone Matrix, a human allograft cellular bone matrix containing bone-derived progenitor cells and conformable bone fibers.

Share on Social Networks: